These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The need for quality control in the developing countries. Perkins FT Dev Biol Stand; 1978; 41():291-4. PubMed ID: 753657 [TBL] [Abstract][Full Text] [Related]
3. Vaccines and medicines for the world's poorest. Quality of vaccines and medicines must be monitored. Arya SC BMJ; 2000 Sep; 321(7264):834. PubMed ID: 11009543 [No Abstract] [Full Text] [Related]
4. The countries' point of view. Schatzmayr HG Vaccine; 1992; 10(13):954. PubMed ID: 1471419 [TBL] [Abstract][Full Text] [Related]
5. Chinese vaccine products go global: vaccine development and quality control. Xu M; Liang Z; Xu Y; Wang J Expert Rev Vaccines; 2015 May; 14(5):763-73. PubMed ID: 25697690 [TBL] [Abstract][Full Text] [Related]
6. Alternatives and developing countries. Milstien JB; Dellepiane N Dev Biol Stand; 1999; 101():203-8. PubMed ID: 10566794 [TBL] [Abstract][Full Text] [Related]
8. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012. Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836 [TBL] [Abstract][Full Text] [Related]
9. Advantages of modern biotechnical developments for vaccine production in developing countries. Seifert HS; Böhnel H Dtsch Tierarztl Wochenschr; 1988; 95(7):266-8. PubMed ID: 3141123 [No Abstract] [Full Text] [Related]
10. [Vaccines and developing countries]. Bjune G Tidsskr Nor Laegeforen; 1991 May; 111(12):1496-9. PubMed ID: 2042182 [TBL] [Abstract][Full Text] [Related]
11. Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all. Pagliusi S; Leite LC; Datla M; Makhoana M; Gao Y; Suhardono M; Jadhav S; Harshavardhan GV; Homma A Vaccine; 2013 Apr; 31 Suppl 2():B176-83. PubMed ID: 23598479 [TBL] [Abstract][Full Text] [Related]
12. China enters the global vaccine market. Parry J Bull World Health Organ; 2014 Sep; 92(9):626-7. PubMed ID: 25378751 [TBL] [Abstract][Full Text] [Related]
13. Reaching international GMP standards for vaccine production: challenges for developing countries. Milstien J; Costa A; Jadhav S; Dhere R Expert Rev Vaccines; 2009 May; 8(5):559-66. PubMed ID: 19397413 [TBL] [Abstract][Full Text] [Related]
14. Vaccine and vaccination. Ghosh AK J Indian Med Assoc; 1982 Apr; 78(8):141-2. PubMed ID: 7130727 [No Abstract] [Full Text] [Related]
15. Regulatory pathways for vaccines for developing countries. Milstien J; Belgharbi L Bull World Health Organ; 2004 Feb; 82(2):128-33. PubMed ID: 15042235 [TBL] [Abstract][Full Text] [Related]
16. [Problems in production, control and utilization of veterinary vaccines in the developing countries]. Provost A Dev Biol Stand; 1978; 41():333-9. PubMed ID: 753662 [TBL] [Abstract][Full Text] [Related]
17. Casting off vaccine supply charity -- the pace quickens. CVI goal: quality vaccines for all children. CVI Forum; 1995 Oct; (10):9-13. PubMed ID: 12290725 [TBL] [Abstract][Full Text] [Related]
19. Vaccines should be more environmentally stable. Arya SC BMJ; 1993 Apr; 306(6885):1130. PubMed ID: 8495184 [No Abstract] [Full Text] [Related]
20. The use of alternatives to animal tests in developing countries. Hong HA; Hendriks J Dev Biol Stand; 1999; 101():209-14. PubMed ID: 10566795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]